Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide plus CHOP in de novo PTCL
NCT03268889Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jun 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tucidinostat in peripheral T-cell lymphoma (PTCL), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Complete Remission Rate at 30 months. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT03268889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03268889.